Jeffery J. Anderson

发表

Reductions in beta-amyloid concentrations in vivo by the gamma-secretase inhibitors BMS-289948 and BMS-299897.

S. Wagner, B. Lamb, D. Barten, 2005, Biochemical pharmacology.

Discovery of novel modulators of metabotropic glutamate receptor subtype-5.

B. Muñoz, M. F. Gardner, Janice Chung, 2004, Bioorganic & medicinal chemistry.

[3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine Binding to Metabotropic Glutamate Receptor Subtype 5 in Rodent Brain: In Vitro and in Vivo Characterization

Nicholas D. P. Cosford, N. Cosford, M. Bradbury, 2002, Journal of Pharmacology and Experimental Therapeutics.

5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3'-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activity.

Dehua Huang, N. Cosford, B. Muñoz, 2004, Bioorganic & medicinal chemistry letters.

Dynamics of β-Amyloid Reductions in Brain, Cerebrospinal Fluid, and Plasma of β-Amyloid Precursor Protein Transgenic Mice Treated with a γ-Secretase Inhibitor

David W. Smith, J. Hendrick, T. Verdoorn, 2005, Journal of Pharmacology and Experimental Therapeutics.

A neurotrophic approach to treating hearing loss: Translation from animal models to clinical proof-of-concept.

F. Piu, Victoria A Sanchez, A. Foster, 2022, The Journal of the Acoustical Society of America.

Activation of spinal group I metabotropic glutamate receptors in rats evokes local glutamate release and spontaneous nociceptive behaviors: effects of 2-methyl-6-(phenylethynyl)-pyridine pretreatment

D. Lorrain, Jeffery J. Anderson, M. Varney, 2002, Neuroscience Letters.

Group II mGlu Receptor Activation Suppresses Norepinephrine Release in the Ventral Hippocampus and Locomotor Responses to Acute Ketamine Challenge

D. Lorrain, L. Bristow, A. Pinkerton, 2003, Neuropsychopharmacology.

Reductions in β-amyloid concentrations in vivo by the γ-secretase inhibitors BMS-289948 and BMS-299897

S. Wagner, B. Lamb, D. Barten, 2005 .

The Behavioral Profile of the Potent and Selective mGlu5 Receptor Antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in Rodent Models of Anxiety

N. Cosford, L. Bristow, Jeffery J. Anderson, 2004, Neuropsychopharmacology.

In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine).

N. Cosford, M. Bradbury, Jeffery J. Anderson, 2003, European journal of pharmacology.

Dipyridyl amines: potent metabotropic glutamate subtype 5 receptor antagonists.

T. Kamenecka, C. Bonnefous, J. Vernier, 2005, Bioorganic & medicinal chemistry letters.